Tuning In To Cough in Pulmonary Fibrosis: How Should We Address the Gap?
ATS 2025 Innovation Hub PresentationToby Maher, MD, PHD, Professor of Clinical Medicine at Keck School of Medicine, USC
Cough as an Endpoint in IPF Trials: Why it Matters
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients feel and function is a dry, persistent cough. Due to its consistent correlation with […]
Strados Named a Finalist in the ATA Telehealth Innovators Challenge
[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ custom_padding=”33px|||||” global_colors_info=”{}”][et_pb_row admin_label=”row” _builder_version=”4.16″ min_height=”948.5px” custom_padding=”0px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_heading title=”Nick Delmonico, CEO of Strados Labs will be presenting on behalf of the company at ATA’s Annual Conference on March 6th – where Strados will also be exhibiting.” _builder_version=”4.24.0″ _module_preset=”default” title_level=”h2″ title_font_size=”22px” title_line_height=”1.2em” global_colors_info=”{}”][/et_pb_heading][et_pb_text admin_label=”Text” _builder_version=”4.24.0″ header_font_size=”23px” header_line_height=”1.3em” header_4_font_size=”19px” […]